logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/09/2025
Nvidia-backed artificial intelligence startup Reflection is close to completing a deal valued at $5.5 billion.
Latest
2 m ago
Global aluminum market is shifting: facing shortage in 2026, prices aiming for $3000 per ton!
3 m ago
Jiaxin Wealth Management: "25 basis points" is "most favorable" for financial assets, significant interest rate cuts may cause panic.
4 m ago
Every AI Express, Shanxi Securities released a research report on September 9, giving Yonggui Electric (300351.SZ) a "buy" rating. The main reasons for the rating include: 1) 25H1 increase in revenue but not in profit, continuing to reduce costs and increase efficiency; 2) continuous breakthrough in high-power charging technology for new energy vehicles; 3) forward-looking layout in emerging areas to cultivate future growth points. (Daily Economic News)
4 m ago
According to a report released by Shanxi Securities on September 9th, Shanxi Coal International (600546.SH) has been given a "buy" rating. The main reasons for the rating include: 1) increased production, with improvements in coal production and sales in the second quarter; 2) a commitment to high dividends, with dividend value expected in the future. (Daily Economic News)
4 m ago
According to AI Express, China Post Securities released a research report on September 9 giving Jiangsu Hengrui Medicine Co., Ltd. (600276.SH) a "buy" rating. The reasons for the rating mainly include: 1) The license revenue in the first half of 2025 reached 1.99 billion yuan, with steady growth in innovative drugs; 2) The research and development of oncology and chronic disease immunotherapy are progressing simultaneously, and the employee stock ownership plan clearly outlines the future output plan for innovative drugs. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.